Preliminary evidence for feasibility, use, and acceptability of individualized texting for adherence building for antiretroviral adherence and substance use assessment among HIV-infected methamphetamine users

AIDS Research and Treatment

Volumn 2013, Issue , 2013, Pages

  Moore, David J ^a,b   Montoya, Jessica L ^b,c   Blackstone, Kaitlin ^b,c   Rooney, Alexandra ^a,b   Gouaux, Ben ^a,b   Georges, Shereen ^a,b   Depp, Colin A ^a,d   Atkinson, J Hampton ^a,b,d   Tmarc Group, The ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HIV Neurobehavioral Research Program   (United States)

^c SAN DIEGO STATE UNIVERSITY   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884885699     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2013/585143     Document Type: Article

References (38)

1. Kaplan R. M., Stone A. A., Bringing the laboratory and clinic to the community: mobile technologies for health promotion and disease prevention. Annual Review of Psychology 2013 64 471 498 10.1146/annurev-psych-113011-143736
2. Heron K. E., Smyth J. M., Ecological momentary interventions: Incorporating mobile technology into psychosocial and health behaviour treatments. British Journal of Health Psychology 2010 15 1 1 39 2-s2.0-75149156604 10.1348/135910709X466063
3. Krishna S., Boren S. A., Balas E. A., Healthcare via cell phones: a systematic review. Telemedicine and e-Health 2009 15 3 231 240 2-s2.0-65349185553 10.1089/tmj.2008.0099
4. Free C., Whittaker R., Knight R., Abramsky T., Rodgers A., Roberts I. G., Txt2stop: a pilot randomised controlled trial of mobile phone-based smoking cessation support. Tobacco Control 2009 18 2 88 91 2-s2.0-63449109888 10.1136/tc.2008.026146
5. Rodgers A., Corbett T., Bramley D., Riddell T., Wills M., Lin R.-B., Jones M., Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging. Tobacco Control 2005 14 4 255 261 2-s2.0-23744450472 10.1136/tc.2005.011577 (Pubitemid 41128902)
6. Nachega J. B., Hislop M., Dowdy D. W., Chaisson R. E., Regensberg L., Maartens G., Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Annals of Internal Medicine 2007 146 8 564 573 2-s2.0-34247583029 (Pubitemid 351650537)
7. Perienti J.-J., Massari V., Descamps D., Vabret A., Bouvet E., Larouzé B., Verdon R., Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clinical Infectious Diseases 2004 38 9 1311 1316 2-s2.0-2342589337 10.1086/383572 (Pubitemid 38608576)
8. Hardy H., Kumar V., Doros G., Farmer E., Drainoni M.-L., Rybin D., Myung D., Jackson J., Backman E., Stanic A., Skolnik P. R., Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy. AIDS Patient Care and STDs 2011 25 3 153 161 2-s2.0-79952530827 10.1089/apc.2010.0006
9. Lester R. T., Ritvo P., Mills E. J., Kariri A., Karanja S., Chung M. H., Jack W., Habyarimana J., Sadatsafavi M., Najafzadeh M., Marra C. A., Estambale B., Ngugi E., Ball T. B., Thabane L., Gelmon L. J., Kimani J., Ackers M., Plummer F. A., Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. The Lancet 2010 376 9755 1838 1845 2-s2.0-78649456108 10.1016/S0140-6736(10)61997-6
10. Pop-Eleches C., Thirumurthy H., Habyarimana J. P., Zivin J. G., Goldstein M. P., De Walque D., MacKeen L., Haberer J., Kimaiyo S., Sidle J., Ngare D., Bangsberg D. R., Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS 2011 25 6 825 834 2-s2.0-79953755714 10.1097/QAD.0b013e32834380c1
11. Ybarra M. L., Bull S. S., Current trends in Internet-and cell phone-based HIV prevention and intervention programs. Current HIV/AIDS Reports 2007 4 4 201 207 2-s2.0-38349065277 10.1007/s11904-007-0029-2
12. Hinkin C. H., Barclay T. R., Castellon S. A., Levine A. J., Durvasula R. S., Marion S. D., Myers H. F., Longshore D., Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior 2007 11 2 185 194 2-s2.0-33847282357 10.1007/s10461-006-9152-0
13. Marquez C., Mitchell S. J., Hare C. B., John M., Klausner J. D., Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006. AIDS Care 2009 21 5 575 582 2-s2.0-70349759861 10.1080/ 09540120802385579
14. McClure E. A., Acquavita S. P., Harding E., Stitzer M. L., Utilization of communication technology by patients enrolled in substance abuse treatment. Drug and Alcohol Dependence 2013 129 1-2 145 150 10.1016/j.drugalcdep.2012.10. 003
15. Marsch L. A., Dallery J., Advances in the psychosocial treatment of addiction: the role of technology in the delivery of evidence-based psychosocial treatment. Psychiatric Clinics of North America 2012 35 2 481 493 10.1016/j.psc.2012.03.009
16. Boyer E. W., Smelson D., Fletcher R., Ziedonis D., Picard R. W., Wireless technologies, ubiquitous computing and mobile health: application to drug abuse treatment and compliance with HIV therapies. Journal of Medical Toxicology 2010 6 2 212 216 2-s2.0-77956188197 10.1007/s13181-010-0080-z
17. Colfax G., Shoptaw S., The methamphetamine epidemic: implications for HIV prevention and treatment. Current HIV/AIDS Reports 2005 2 4 194 199 2-s2.0-33644835175
18. Gibson D. R., Leamon M. H., Flynn N., Epidemiology and public health consequences of methamphetamine use in California's Central Valley. Journal of Psychoactive Drugs 2002 34 3 313 319 2-s2.0-0036660897 (Pubitemid 35204602)
19. Halkitis P. N., Green K. A., Carragher D. J., Methamphetamine use, sexual behavior, and HIV seroconversion. Journal of Gay and Lesbian Psychotherapy 2006 10 3-4 95 109 2-s2.0-33747598050 10.1300/J236v10n03-09 (Pubitemid 44275757)
20. Hinkin C. H., Hardy D. J., Mason K. I., Castellon S. A., Durvasula R. S., Lam M. N., Stefaniak M., Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS 2004 18 supplement 1 S19 S25 2-s2.0-1642358930 10.1097/00002030-200406002-00003
21. Ellis R. J., Childers M. E., Cherner M., Lazzaretto D., Letendre S., Grant I., Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. Journal of Infectious Diseases 2003 188 12 1820 1826 2-s2.0-0346059314 10.1086/379894 (Pubitemid 38064866)
22. Moore D. J., Blackstone K., Woods S. P., Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. AIDS Care 2012 24 12 1504 1513
23. Gifford A. L., Bormann J. E., Shively M. J., Wright B. C., Richman D. D., Bozzette S. A., Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes 2000 23 5 386 395 2-s2.0-0034655019 (Pubitemid 30431595)
24. Hinkin C. H., Castellon S. A., Durvasula R. S., Hardy D. J., Lam M. N., Mason K. I., Thrasher D., Goetz M. B., Stefaniak M., Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 2002 59 12 1944 1950 2-s2.0-0037168812 (Pubitemid 36076569)
25. Hirsch M. S., Brun-Vézinet F., D'Aquila R. T., Hammer S. M., Johnson V. A., Kuritzkes D. R., Loveday C., Mellors J. W., Clotet B., Conway B., Demeter L. M., Vella S., Jacobsen D. M., Richman D. D., Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an international AIDS society-USA panel. Journal of the American Medical Association 2000 283 18 2417 2426 2-s2.0-0343183245 (Pubitemid 30257541)
26. Collins L. M., Murphy S. A., Strecher V., The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions. American Journal of Preventive Medicine 2007 32 5, supplement S112 S118 2-s2.0-34247364640 10.1016/j.amepre.2007.01.022 (Pubitemid 46634959)
27. Collins L. M., Murphy S. A., Nair V. N., Strecher V. J., A strategy for optimizing and evaluating behavioral interventions. Annals of Behavioral Medicine 2005 30 1 65 73 2-s2.0-23944452846 10.1207/s15324796abm3001-8 (Pubitemid 41208987)
28. Riley W. T., Glasgow R. E., Etheredge L., Abernethy A. P., Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise. Clinical and Translational Medicine 2013 2 1 10
29. World Health Organization, Composite International Diagnostic Interview (CIDI, Version 2.1) 1997 Geneva, Switzerland World Health Organization
30. Moore D. J., Posada C., Parikh M., Arce M., Vaida F., Riggs P. K., Gouaux B., Ellis R. J., Letendre S. L., Grant I., Atkinson J. H., HIV-infected individuals with co-occurring bipolar disorder evidence poor antiretroviral and psychiatric medication adherence. AIDS and Behavior 2012 16 8 2257 2266 2-s2.0-80055018756 10.1007/s10461-011-0072-2
31. Montoya J. L., Georges S., Poquette A., Depp C. A., Atkinson J. H., Moore D. J., Developing content for a mobile medication adherence intervention for HIV+ methamphetamine users. (under review)
32. Johnson M. O., Catz S. L., Remien R. H., Rotheram-Borus M. J., Morin S. F., Charlebois E., Gore-Felton C., Goldsten R. B., Wolfe H., Lightfoot M., Chesney M. A., Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project. AIDS Patient Care and STDs 2003 17 12 645 656 2-s2.0-9144265457 10.1089/ 108729103771928708 (Pubitemid 38031552)
33. Roberts K. J., Barriers to and facilitators of HIV-positive patients' adherence to antiretroviral treatment regimens. AIDS Patient Care and STDs 2000 14 3 155 168 2-s2.0-0034074916 10.1089/108729100317948 (Pubitemid 30185387)
34. Hser Y.-I., Anglin M. D., Chou C.-P., Reliability of retrospective self-report by narcotics addicts. Psychological Assessment 1992 4 2 207 213 2-s2.0-0000993495
35. Phillips K. A., Epstein D. H., Preston K. L., Daily temporal patterns of heroin and cocaine use and craving: relationship with business hours regardless of actual employment status. Addictive Behaviors 2013 38 10 2485 2491
36. Rippeth J. D., Heaton R. K., Carey C. L., Marnotte T. S., Moore D. J., Gonzalez R., Wolfson T., Grant I., Atkinson J. H., McCutchan J. A., Marcotte T. D., Wallace M. R., Ellis R. J., Letendre S., Schrier R., Heaton R. K., Cherner M., Rippeth J., Sadek J., Woods S. P., Jernigan T., Hasselink J., Masliah E., Maysy D. R., Frybarger M., Abramson I., Deutsch R., Lazzaretto D., Wolfson T., Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society 2004 10 1 1 14 2-s2.0-9144232221 10.1017/S1355617704101021 (Pubitemid 38128457)
37. Thirumurthy H., Lester R. T., M-health for health behaviour change in resource-limited settings: applications to HIV care and beyond. Bulletin of the World Health Organization 2012 90 5 390 392 2-s2.0-84860434809 10.2471/BLT.11.099317
38. Yang X., Li J., Shoptaw S., Imputation-based strategies for clinical trial longitudinal data with nonignorable missing values. Statistics in Medicine 2008 27 15 2826 2849 2-s2.0-47249109100 10.1002/sim.3111 (Pubitemid 351982679)